Related Experiment Video
Updated: Jun 7, 2025

06:10
Transplantation of Neonatal Mouse Cardiac Macrophages into Adult Mice
Published on: March 20, 2021
2.8K
Targeting Macrophage Phenotype for Treating Heart Failure: A New Approach
Min Shi1,2, Hui Yuan2,3, Ya Li4
1School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
Drug Design, Development and Therapy
|November 11, 2024
Summary
Macrophages are key immune cells in heart failure (HF). Targeting macrophage functions like polarization and apoptosis offers promising new therapeutic strategies for HF treatment.
Area of Science:
- Immunology
- Cardiovascular Disease
- Cell Biology
Background:
- Heart failure (HF) presents a significant global health burden with limited treatment options.
- Macrophages, innate immune cells, are increasingly recognized for their critical roles in HF pathogenesis.
- Understanding macrophage functions is crucial for developing novel HF therapies.
Purpose of the Study:
- To review the multifaceted biological functions of macrophages in the context of heart failure.
- To explore how macrophage polarization, pyroptosis, autophagy, and apoptosis contribute to HF development.
- To highlight the therapeutic potential of modulating macrophage phenotypes in HF.
Main Methods:
- Review of current scientific literature on macrophage biology and heart failure.
- Analysis of macrophage functions including phagocytosis, immune response, and tissue repair.
- Discussion of cellular processes like polarization, pyroptosis, autophagy, and apoptosis in HF pathogenesis.
Main Results:
- Macrophages significantly influence cardiac homeostasis and stress responses in HF.
- Key macrophage processes such as polarization, pyroptosis, autophagy, and apoptosis are deeply implicated in HF.
- Modulating macrophage phenotypes can impact immune-inflammation, fibrosis, metabolism, and angiogenesis in HF.
Conclusions:
- Macrophages represent a promising therapeutic target for heart failure.
- Targeting macrophage functions offers potential strategies to improve HF outcomes.
- Further research into macrophage modulation could lead to novel HF treatments.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K

